Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · see citing works

CNS synaptogenesis promoted by glia-derived cholesterol

Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · see citing works

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · see citing works

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157 · see citing works

Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions

William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107 · see citing works

Amyloid β-Protein Fibrillogenesis

Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046 · see citing works

Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989 · see citing works

Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

Hartley, D. M., Walsh, D. M., Ye, C., Diehl, T. S., Vasquez, S., Vassilev, P., Teplow, D. B., & Selkoe, D. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 965 · see citing works

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · see citing works

Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 889 · see citing works

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · see citing works

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830 · see citing works

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829 · see citing works

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802 · see citing works

Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro

Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795 · see citing works

Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

Griffin, W., Sheng, J. G., Royston, M., Gentleman, S., McKenzie, J., Graham, D. I., Roberts, G., & Mrak, R. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 751 · see citing works

Apolipoprotein E and Alzheimer disease.

Strittmatter, W. J., & Roses, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4725 · Cited by 699 · see citing works

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693 · see citing works

Apolipoprotein E in animal models of CNS injury and in alzheimer's disease

Poirier, J. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90156-2 · Cited by 637 · see citing works

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622 · see citing works

Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains

Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618 · see citing works

Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis

Sullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575 · see citing works

Expression of apolipoprotein E during nerve degeneration and regeneration.

Ignatius, M. J., Gebicke‐Haerter, P. J., Skene, J. H. P., Schilling, J., Weisgraber, K. H., Mahley, R. W., & Shooter, E. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1125 · Cited by 568 · see citing works

Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease

Lansbury, P. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3342 · Cited by 553 · see citing works

Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy

Greenberg, S. M., Rebeck, G. W., Vonsattel, J. P., Gómez‐Isla, T., & Hyman, B. T. (1995) · Annals of Neurology · doi:10.1002/ana.410380219 · Cited by 540 · see citing works

Isoform-specific binding of apolipoprotein E to beta-amyloid.

LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540 · see citing works

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.

Boyles, J. K., Zoellner, C. D., Anderson, L. J., Kosik, L. M., Pitas, R. E., Weisgraber, K. H., Hui, D. Y., Mahley, R. W., Gebicke‐Haerter, P. J., & Ignatius, M. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113943 · Cited by 533 · see citing works

Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases

Saunders, A. M., Roses, A. D., Pericak‐Vance, M. A., Dole, K. C., Strittmatter, W. J., Schmechel, D. E., Szymanski, M. H., McCown, N., Manwaring, M., Schmader, K. E., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91709-u · Cited by 498 · see citing works

Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease

Roher, A. E., Chaney, M. O., Kuo, Y., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20631 · Cited by 494 · see citing works

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493 · see citing works

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11183 · Cited by 474 · see citing works

Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

van Duijn, C. M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L. M., Albert Hofman, D., & Broeckhoven, C. V. (1994) · Nature Genetics · doi:10.1038/ng0594-74 · Cited by 453 · see citing works

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

(1994) · PubMed Central · Cited by 441 · see citing works

Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region

Chartier‐Harlin, M., Parfitt, M., Legrain, S., Pérez‐Tur, J., Brousseau, T., Evans, A., Berr, C., Vldal, O., Roques, P. K., Gourlet, V., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.4.569 · Cited by 437 · see citing works

Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype

Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L., Jakes, R., Alberts, M. J., Gilbert, J. R., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1019 · Cited by 433 · see citing works

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., & Roses, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117407 · Cited by 404 · see citing works

Neurodegeneration in the Central Nervous System of apoE-Deficient Mice

Masliah, E., Mallory, M. E., Ge, N., Alford, M. F., Veinbergs, I., & Roses, A. D. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1088 · Cited by 402 · see citing works

Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons

Huang, Y., Liu, X. Q., Wyss-Coray, T., Brecht, W. J., Sanan, D. A., & Mahley, R. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151254698 · Cited by 392 · see citing works

Human Apolipoprotein E Receptor 2

Kim, D.-H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S., & Yamamoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8373 · Cited by 384 · see citing works

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

Poirier, J., Hess, M. A., May, P. C., & Finch, C. E. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90111-a · Cited by 380 · see citing works

Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease

Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378 · see citing works

Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress

Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352 · see citing works

Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line.

Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., & Schwartz, A. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9480 · Cited by 349 · see citing works

Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease

Holtzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A. M., Chang, L. K., Sun, Y., & Paul, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6179 · Cited by 349 · see citing works

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., & Lansbury, P. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.763 · Cited by 333 · see citing works

Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats

Poirier, J., Baccichet, A., Dea, D., & Gauthier, S. G. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90456-p · Cited by 329 · see citing works

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation

Slooter, A. J. C. (1997) · JAMA · doi:10.1001/jama.277.10.818 · Cited by 317 · see citing works

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

Bellosta, S., Nathan, B. P., Orth, M., Dong, L.-M., Mahley, R. W., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27063 · Cited by 313 · see citing works

The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304 · see citing works

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

Diedrich, J. F., Minnigan, H. J., Carp, R. I., Whitaker, J. N., Race, R., Frey, W. H., & Haase, A. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4759-4768.1991 · Cited by 295 · see citing works

Nascent astrocyte particles differ from lipoproteins in CSF

LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285 · cited 1× · see citing works

The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

Nathan, B. P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R. W., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19791 · Cited by 276 · see citing works

Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides

TOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272 · see citing works

Apolipoprotein E: risk factor for Alzheimer disease.

Tsai, M. S., Tangalos, E. G., Petersen, R. C., Smith, G. E., Schaid, D. J., Kokmen, E., Ivnik, R. J., & Thibodeau, S. N. (1994) · PubMed Central · Cited by 265 · see citing works

Apolipoprotein E: Binding to Soluble Alzheimer′s β-Amyloid

Wısnıewskı, T., Golabek, A. A., Matsubara, E., Ghiso, J. A., & Frangione, B. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1423 · Cited by 265 · see citing works

Expression of Human Apolipoprotein E4 in Neurons Causes Hyperphosphorylation of Protein Tau in the Brains of Transgenic Mice

Tesseur, I. C., Dorpe, J. V., Spittaels, K., den Haute, C. V., Moechars, D., & LEUVEN, F. V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64963-2 · Cited by 239 · see citing works

Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNAin Vivoandin Vitro

Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P., Hajian, H., & Finch, C. E. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6360 · Cited by 237 · see citing works

The LDL Receptor Gene Family

Herz, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00234-3 · Cited by 233 · see citing works

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216 · see citing works

Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons

Bu, G., Maksymovitch, E. A., Nerbonne, J. M., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32340-2 · Cited by 216 · see citing works

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.

Sun, Y., Wu, S., Bu, G., Onifade, M. K., Patel, S. N., LaDu, M. J., Fagan, A. M., & Holtzman, D. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03261.1998 · Cited by 213 · see citing works

Lipoprotein Uptake by Neuronal Growth Cones in Vitro

Ignatius, M. J., Shooter, E. M., Pitas, R. E., & Mahley, R. W. (1987) · Science · doi:10.1126/science.3576212 · Cited by 207 · see citing works

Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction

Matsubara, E., Frangione, B., & Ghiso, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7563 · Cited by 195 · see citing works

Reduced apolipoprotein ϵ4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals

Rebeck, G. W., Perls, T. T., West, H. L., Sodhi, P., Lipsitz, L. A., & Hyman, B. T. (1994) · Neurology · doi:10.1212/wnl.44.8.1513 · Cited by 189 · see citing works

Purification of Apolipoprotein E Attenuates Isoform-specific Binding to β-Amyloid

LaDu, M. J., Pederson, T. M., Frail, D. E., Reardon, C. A., Getz, G. S., & Falduto, M. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9039 · Cited by 189 · see citing works

Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response

Lynch, J., Morgan, D., Mance, J., Matthew, W. D., & Laskowitz, D. T. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00459-8 · Cited by 188 · see citing works

Progression of Cerebral Amyloid Angiopathy: Accumulation of Amyloid-ß40 in Affected Vessels

Alonzo, N. C., Hyman, B. T., Rebeck, G. W., & Greenberg, S. M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199804000-00008 · Cited by 185 · see citing works

Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.

Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J., & Mirra, S. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9382 · Cited by 179 · see citing works

Isoform-Specific Effect of Apolipoprotein E on Cell Survival and β-Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures

Jordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., & LaDu, M. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00195.1998 · Cited by 178 · see citing works

Apolipoprotein E suppresses glial cell secretion of TNFα

Laskowitz, D. T., Goel, S., Bennett, E. R., & Matthew, W. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00021-0 · Cited by 175 · see citing works

Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia

Laskowitz, D. T., Sheng, H., Bart, R. D., Joyner, K. A., Roses, A. D., & Warner, D. S. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00005 · Cited by 166 · see citing works

Microglial Activation in Alzheimer Disease: Association with APOE Genotype

Egensperger, R., Kösel, S., von Eitzen, U., & Graeber, M. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00166.x · Cited by 164 · see citing works

SP-40,40 is a constituent of Alzheimer's amyloid

Choi-Miura, N. H., Ihara, Y., Fukuchi, K., Takeda, M., Nakano, Y., Tobe, T., & Tomita, M. (1992) · Acta Neuropathologica · doi:10.1007/bf00296787 · Cited by 158 · see citing works

Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease

Frisoni, G. B., Govoni, S., Geroldi, C., Bianchetti, A., Calabresi, L., Franceschini, G., & Trabucchi, M. (1995) · Annals of Neurology · doi:10.1002/ana.410370509 · Cited by 149 · see citing works

Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity

Tolar, M., Keller, J. N., Chan, S., Mattson, M. P., Marques, M. A., & Crutcher, K. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07100.1999 · Cited by 148 · see citing works

Neuropathological Changes in Down's Syndrome Hippocampal Formation

Hyman, B. T. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280059019 · Cited by 147 · see citing works

Interaction of Nascent ApoE2, ApoE3, and ApoE4 Isoforms Expressed in Mammalian Cells with Amyloid Peptide β (1−40). Relevance to Alzheimer's Disease

Aleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138 · see citing works

ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain

Uchihara, T., Duyckaerts, C., He, Y., Kobayashi, K., Seilhean, D., Amouyel, P., & Hauw, J.-J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11763-m · Cited by 131 · see citing works

A Mechanism for the Neuroprotective Effect of Apolipoprotein E

Pedersen, W. A., Chan, S. L., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741426.x · Cited by 130 · see citing works

Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.

Urmoneit, B., Prikulis, I., Wihl, G. E., D’Urso, D., Frank, R. W., Heeren, J., Beisiegel†, U., & Prior, R. (1997) · PubMed · Cited by 124 · see citing works

Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses

LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00050-x · Cited by 118 · see citing works

Expression of the Very Low-Density Lipoprotein Receptor (VLDL-r), an Apolipoprotein-E Receptor, in the Central Nervous System and in Alzheimerʼs Disease

Christie, R. H., Chung, H., Rebeck, G. W., Strickland, D. K., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199604000-00012 · Cited by 113 · see citing works

Characterization of the Binding of Amyloid‐β Peptide to Cell Culture‐Derived Native Apolipoprotein E2, E3, and E4 Isoforms and to Isoforms from Human Plasma

Yang, D., Smith, J. D., Zhou, Z., Gandy, S. E., & Martins, R. N. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020721.x · Cited by 111 · see citing works

Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury

Stoll, G., & Müller, H. W. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90519-7 · Cited by 108 · see citing works

Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner

Yang, D.-S., Small, D. H., Seydel, U., Smith, J. D., Hallmayer, J. F., Gandy, S., & Martins, R. N. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00561-2 · Cited by 108 · see citing works

Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides

Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108 · see citing works

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome

Lai, F., Kammann, Η., Rebeck, G. W., Anderson, A. J., Chen, Y., & Nixon, R. A. (1999) · Neurology · doi:10.1212/wnl.53.2.331 · Cited by 105 · see citing works

Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities

Sabo, T., Lomnitski, L., Nyska, A., Beni, S., Maronpot, R. R., Shohami, E., Roses, A. D., & Michaelson, D. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00438-3 · Cited by 104 · see citing works

Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures

LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Eldik, L. J. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 101 · see citing works

Protofibrils, the unifying toxic molecule of neurodegenerative disorders?

Haass, C., & Steiner, H. (2001) · Nature Neuroscience · doi:10.1038/nn0901-859 · Cited by 99 · see citing works

A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity

Marques, M. A., Tolar, M., Harmony, J. A. K., & Crutcher, K. A. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00025 · Cited by 97 · see citing works

Amyloid β‐Protein, APOE Genotype and Head Injury

Nicoll, J. A. R., Roberts, G. W., & Graham, D. I. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34431.x · Cited by 96 · see citing works

The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.

Yu, C., Payami, H., Olson, J. M., Boehnke, M., Wijsman, E. M., Orr, H. T., Kukull, W. A., Goddard, K. A. B., Nemens, E. J., & White, J. A. (1994) · PubMed Central · Cited by 94 · see citing works

Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity

Metzger, R. E., LaDu, M. J., Pan, J. B., Getz, G. S., Frail, D. E., & Falduto, M. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199603000-00013 · Cited by 94 · see citing works

Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP V717F transgenic mice

Irizarry, M. C., Cheung, B. S., Rebeck, G. W., Paul, S. M., Bales, K. R., & Hyman, B. T. (2000) · Acta Neuropathologica · doi:10.1007/s004010000263 · Cited by 93 · see citing works

Apolipoprotein E genes in Lewy body and Parkinson's disease

Benjamin, R., Leake, A., Edwardson, J. A., McKeith, I. G., Ince, P. G., Perry, R. H., & Morris, C. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92961-0 · Cited by 93 · see citing works

Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture.

Teter, B., Xu, P. ‐., Gilbert, J. R., Roses, A. D., Galasko, D., & Cole, G. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732613.x · Cited by 88 · see citing works

Expression of ?2-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells

Marzolo, M., Rommy von Bernhardi, M., Bu, G., & Inestrosa, N. C. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000501)60:3 · Cited by 87 · see citing works

Apolipoprotein E ϵ4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis

Mui, S., Rebeck, G. W., McKenna-Yasek, D. M., Hyman, B. T., & Brown, R. H. (1995) · Annals of Neurology · doi:10.1002/ana.410380318 · Cited by 85 · see citing works

Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease

Huang, D. Y., Goedert, M., Jakes, R., Weisgraber, K. H., Garner, C. C., Saunders, A. M., Pericak‐Vance, M. A., Schmechel, D. E., Roses, A. D., & Strittmatter, W. J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90204-6 · Cited by 83 · see citing works

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production

Laskowitz, D. T., Matthew, W. D., Bennett, E. R., Schmechel, D. E., Herbstreith, M. H., Goel, S., & McMillian, M. (1998) · Neuroreport · doi:10.1097/00001756-199803090-00010 · Cited by 83 · see citing works

Differential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins

Fleming, L. M., Weisgraber, K. H., Strittmatter, W. J., Troncoso, J. C., & Johnson, G. V. W. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0064 · Cited by 82 · cited 1× · see citing works

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures

Beffert, U., Aumont, N., Dea, D., Lussier‐Cacan, S., Davignon, J., & Poirier, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00073-x · Cited by 80 · see citing works

Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures

Puttfarcken, P. S., Manelli, A. M., Falduto, M. T., Getz, G. S., & LaDu, M. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020760.x · Cited by 79 · see citing works

Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice

Krzywkowski, P., Ghribi, O., Gagné, J., Chabot, C., Kar, S., Rochford, J., Massicotte, G., & Poirier, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00061-5 · Cited by 74 · see citing works

Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E.

Zhou, Z., Smith, J. D., Greengard, P., & Gandy, S. (1996) · PubMed Central · Cited by 71 · see citing works

Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures

Teter, B., Harris‐White, M. E., Frautschy, S. A., & Cole, G. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00630-7 · Cited by 70 · see citing works

Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype

Licastro, F., Mallory, M., Hansen, L. A., & Masliah, E. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00096-4 · Cited by 70 · see citing works

Astrogliosis and the ApoE Genotype

Overmyer, M., Helisalmi, S., Soininen, H. S., Laakso, M., Riekkinen, P., & Alafuzoff, I. I. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017128 · Cited by 68 · see citing works

Cholesterol from Degenerating Nerve Myelin Becomes Associated with Lipoproteins Containing Apolipoprotein E

Goodrum, J. F. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03469.x · Cited by 66 · see citing works

Attenuation of the Neurotoxic Effect of Aβ Amyloid Peptide by Apolipoprotein E

Whitson, J. S., Mims, M. P., Strittmatter, W. J., Yamaki, T., Morrisett, J. D., & Appel, S. H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1209 · Cited by 66 · see citing works

Amyloid β‐Peptide Effects on Synaptosomes from Apolipoprotein E‐Deficient Mice

Keller, J. N., Lauderback, C. M., Butterfield, D. A., Kindy, M. S., Yu, J., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741579.x · Cited by 63 · see citing works

Apolipoprotein E Attenuates β‐Amyloid‐Induced Astrocyte Activation

Hu, J., LaDu, M. J., & Eldik, L. J. V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041626.x · Cited by 62 · see citing works

Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese

Mak, Y. T., Chiu, H. F. K., Woo, J., Kay, R., Chan, Y. S., Hui, E., Sze, K. H., Lum, C., Kwok, T. C. Y., & Pang, C. P. (1996) · Neurology · doi:10.1212/wnl.46.1.146 · Cited by 61 · see citing works

Alzheimer's disease and apolipoprotein e‐4 allele in an amish population

Pericak‐Vance, M. A., Johnson, C. C., Rimmler, J. B., Saunders, A. M., Robinson, L. C., D'Hondr, E. G., Jackson, C. E., & Haines, J. L. (1996) · Annals of Neurology · doi:10.1002/ana.410390605 · Cited by 60 · see citing works

Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: Colocalization with amyloid plaques

Mufson, E. J., Benzing, W. C., Cole, G. M., Wang, H., Emerich, D. F., Sladek, J. R., Morrison, J. H., & Kordower, J. H. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00064-6 · Cited by 58 · see citing works

ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation

Huang, D. Y., Weisgraber, K. H., Goedert, M., Saunders, A. M., Roses, A. D., & Strittmatter, W. J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11649-h · Cited by 57 · see citing works

Alzheimer β Amyloid Deposition Enhanced by ApoE ɛ4 Gene precedes Neurofibrillary pathology in the Frontal Association Cortex of Nondemented Senior Subjects

Yamaguchi, H., Sugihara, S., Ogawa, A., Oshima, N., & Ihara, Y. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.7.731 · Cited by 56 · see citing works

ApoE protects cortical neurones against neurotoxicity induced by the non‐fibrillar C‐terminal domain of the amyloid‐β peptide

Drouet, B., Fifre, A., Pinçon‐Raymond, M., Vandekerckhove, J. S., Rosseneu, M., Guéant, J., Chambaz, J., & Pillot, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00047.x · Cited by 56 · see citing works

Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.

Benzing, W. C., & Mufson, E. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90021-7 · Cited by 56 · see citing works

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes

Zareparsi, S., Kaye, J. A., Camicioli, R. M., Grimslid, H., Oken, B., Litt, M. J., Nutt, J. G., Bird, T. D., Schellenberg, G. D., & Payami, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420417 · Cited by 54 · see citing works

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

Broderick, J. P., Lü, M., Jackson, C., Pancioli, A., Tilley, B. C., Fagan, S. C., Kothari, R., Levine, S. R., Marler, J. R., Lyden, P. D., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1058 · Cited by 54 · see citing works

Isoform‐Specific Modulation by Apolipoprotein E of the Activities of Secreted β‐Amyloid Precursor Protein

Barger, S. W., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010060.x · Cited by 52 · see citing works

Apolipoprotein E and Low‐Density Lipoprotein Binding and Internalization in Primary Cultures of Rat Astrocytes: Isoform‐Specific Alterations

Guillaume, D., Bertrand, P., Dea, D., Davignon, J., & Poirier, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062410.x · Cited by 51 · see citing works

Selective retinal pigment epithelial cell lipid metabolism and remodeling conserves photoreceptor docosahexaenoic acid following phagocytosis

Turco, E., Parkins, N., Ershov, A. V., & Bazan, N. G. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4 · Cited by 51 · see citing works

Chapter 14 Apolipoprotein E in nerve injury and repair

Ignatius, M. J., Gebicke‐Haerter, P. J., Pitas, R. E., & Shooter, E. M. (1987) · Progress in brain research · doi:10.1016/s0079-6123(08)61822-1 · Cited by 50 · see citing works

Apolipoprotein E gene expression in astrocytes: developmental pattern and regulation

Mouchel, Y., Lefrançois, T., Fages, C., & Tardy, M. (1995) · Neuroreport · doi:10.1097/00001756-199512290-00049 · Cited by 50 · see citing works

The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent

Smith, J. D., Miyata, M., Poulin, S., Neveux, L. M., & Craig, W. Y. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050030 · Cited by 49 · see citing works

Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice

Bi, X., Yong, A. P., Zhou, J., Ribak, C. E., & LYNCH, G. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151253098 · Cited by 43 · see citing works

Role of Apolipoprotein E Receptors in Regulating the Differential in vivo Neurotrophic Effects of Apolipoprotein E

Veinbergs, I., Uden, E. V., Mallory, M. E., Alford, M. F., McGiffert, C., DeTeresa, R. M., Orlando, R. A., & Masliah, E. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7684 · Cited by 39 · see citing works

Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor κB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E

Petegnief, V., Saura, J., DeGregorio‐Rocasolano, N., & Paul, S. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00046-x · Cited by 39 · see citing works

Co-localization of β-amyloid peptides, apolipoprotein E and glial markers in senile plaques in the prefrontal cortex of old rhesus monkeys

Härtig, W., Brückner, G., Schmidt, C., Brauer, K., Bodewitz, G., Turner, J. D., & Bigl, V. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01423-0 · Cited by 36 · see citing works

Apolipoprotein E deposition and astrogliosis are associated with maturation of β-amyloid plaques in βAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer’s disease

Terai, K., Iwai, A., Kawabata, S., Sasamata, M., Miyata, K., & Yamaguchi, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02202-8 · Cited by 35 · see citing works

Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice

Chapman, S., Sabo, T., Roses, A. D., & Michaelson, D. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00087-7 · Cited by 33 · see citing works

Synaptic alterations in apolipoprotein E knockout mice

Veinbergs, I., & Masliah, E. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00602-2 · Cited by 32 · see citing works

Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain

Fujita, S. C., Sakuta, K., Tsuchiya, R., & Hamanaka, H. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00075-9 · Cited by 32 · see citing works

A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic

DeMattos, R. B., Thorngate, F. E., & Williams, D. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02464.1999 · Cited by 30 · see citing works

Differential Regulation of Astrocytic mRNAs in the Rat Striatum after Lesions of the Cortex or Substantia Nigra

Schauwecker, P. E., Cogen, J. P., Jiang, T., Cheng, H. W., Collier, T. J., & McNeill, T. H. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6679 · Cited by 28 · see citing works

Apolipoprotein E and Alzheimer's

BOCKXMEER, F. M. V. (1995) · Nature · doi:10.1038/375285b0 · Cited by 26 · see citing works

Glial Cells in Alzheimer's Disease: Preferential Effect of APOE Risk on Scattered Microglia

Saitoh, T., Kang, D. E., Mallory, M. E., Teresa, R. D., & Masliah, E. (2009) · Gerontology · doi:10.1159/000213839 · Cited by 23 · see citing works

Association of human, rat, and rabbit apolipoprotein E with β‐amyloid

LaDu, M. J., Lukens, J. R., Reardon, C. A., & Getz, G. S. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970701)49:1

Untitled work

Cole (2000) · doi:10.1002/1097-0029(20000815)50:4

Small assemblies of unmodified amyloid $beta;-protein are the proximate neurotoxin in Alzheimer?s disease

Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 487 · see citing works

ApoE4: an emerging therapeutic target for Alzheimer’s disease

Safieh, M., Korczyn, A. D., & Michaelson, D. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1299-4 · Cited by 449 · see citing works

Autocrine and Paracrine Calcium Signaling by the CD38/NAD+/Cyclic ADP‐Ribose System

FLORA, A. D., Zocchi, E., Guida, L., Franco, L., & Bruzzone, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.021 · Cited by 235 · see citing works

The ups and downs of Wnt signaling in prevalent neurological disorders

Ferrari, G. V. D., & Moon, R. T. (2006) · Oncogene · doi:10.1038/sj.onc.1210064 · Cited by 221 · see citing works

Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis

Kim, J., Jiang, H., Park, S., Eltorai, A. E. M., Stewart, F. R., Yoon, H., Basak, J. M., Finn, M. B., & Holtzman, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3773-11.2011 · Cited by 199 · see citing works

Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis

Wood, W. G., Li, L., Müller, W. E., & Eckert, G. P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12637 · Cited by 194 · see citing works

Apolipoprotein E and cholesterol in aging and disease in the brain

de Chaves, E. P., Narayanaswami, V., Christoffersen, C., & Nielsen, L. B. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.505 · Cited by 164 · see citing works

Hippocampal and Cognitive Aging across the Lifespan: A Bioenergetic Shift Precedes and Increased Cholesterol Trafficking Parallels Memory Impairment

Kadish, I., Thibault, O., Blalock, E. M., Chen, K.-C., Gant, J. C., Porter, N. M., & Landfield, P. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4599-08.2009 · Cited by 152 · see citing works

Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk

Huang, Y.-W. A., Zhou, B., Nabet, A. M., Wernig, M., & Südhof, T. C. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2994-18.2019 · Cited by 152 · see citing works

Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease

Frieden, C., & Garai, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207022109 · Cited by 133 · see citing works

Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.

Rapp, A., Gmeiner, B., & Hüttinger, M. (2006) · Biochimie · doi:10.1016/j.biochi.2005.10.007 · Cited by 137 · see citing works

Wnt/β-Catenin Signaling in Alzheimer’s Disease

Ferrari, G., Avila, M., Medina, M., Perez-Palma, E., Bustos, B., & Alarcon, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223113900 · Cited by 95 · see citing works

Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study

Babiloni, C., Benussi, L., Binetti, G. G., Cassetta, E., Forno, G. D., Percio, C. D., Ferreri, F., Ferri, R., Frisoni, G. B., Ghidoni, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20724 · Cited by 92 · see citing works

Selective loss of synaptic proteins in Alzheimer's disease: Evidence for an increased severity with APOE ɛ4

Tannenberg, R. K., Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.05.004 · Cited by 89 · see citing works

Lipid Rafts in Neurodegeneration and Neuroprotection

Sonnino, S., Aureli, M., Grassi, S., Mauri, L., Prioni, S., & Prinetti, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8614-4 · Cited by 85 · see citing works

Association of APOEpolymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study

Chu, A. Y., Parekh, R. S., Astor, B. C., Coresh, J., Berthier‐Schaad, Y., Smith, M. W., Shuldiner, A. R., & Kao, W. H. L. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-108 · Cited by 84 · see citing works

ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42

Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Blaine Stine, W., Manelli, A., Sullivan, P., Pasternak, J. F., & LaDu, M. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.011 · Cited by 82 · see citing works

Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies

Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82 · see citing works

The role of APOE in transgenic mouse models of AD

Balu, D., Karstens, A. J., Loukenas, E., Maldonado Weng, J., York, J. M., Valencia-Olvera, A. C., & LaDu, M. J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134285 · Cited by 81 · see citing works

Lipids in Amyloid-β Processing, Aggregation, and Toxicity

Morgado, I., & Garvey, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_3 · Cited by 69 · see citing works

Folate deprivation increases presenilin expression, gamma‐secretase activity, and Abeta levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S‐adenosyl methionine

Chan, A., & Shea, T. B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04589.x · Cited by 71 · see citing works

Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

Ashrafian, H., Harling, L., Darzi, A. W., & Athanasiou, T. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9412-4 · Cited by 71 · see citing works

Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease

Hostage, C. A., Choudhury, K. R., Doraiswamy, P. M., Petrella, J. R., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054483 · Cited by 71 · see citing works

Alzheimer’s Disease and Stem Cell Therapy

Choi, S. S., Lee, S., Kim, S. U., & Lee, H. J. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.45 · Cited by 62 · see citing works

HDL Proteome and Alzheimer’s Disease: Evidence of a Link

Marsillach, J., Adorni, M. P., Zimetti, F., Papotti, B., Zuliani, G., & Cervellati, C. (2020) · Antioxidants · doi:10.3390/antiox9121224 · Cited by 57 · see citing works

Apolipoprotein E Dose-Dependent Modulation of β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease

DeMattos, R. B. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:255 · Cited by 55 · see citing works

Clinical phenotype, atrophy, and small vessel disease in APOE ε2 carriers with Alzheimer disease

Groot, C., Sudre, C. H., Barkhof, F., Teunissen, C. E., van Berckel, B. N. M., Seo, S. W., Sebastien Ourselin, A., Scheltens, P., Cardoso, M. J., van der Flier, W. M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006503 · Cited by 53 · see citing works

Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease

Mamun, A. A., Uddin, M. S., Bashar, M. F. B., Zaman, S., Begum, Y., Bulbul, I. J., Islam, M. S., Sarwar, M. S., Mathew, B., Amran, M. S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5086250 · Cited by 53 · see citing works

Dietary and genetically-induced oxidative stress alter tau phosphorylation: Influence of folate and apolipoprotein E deficiency

Chan, A., & Shea, T. B. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9405 · Cited by 53 · see citing works

Cardiovascular Risk Factors Associated with Smaller Brain Volumes in Regions Identified as Early Predictors of Cognitive Decline

Srinivasa, R. N., Rossetti, H. C., Gupta, M. K., Rosenberg, R. N., Weiner, M., Peshock, R. M., McColl, R. W., Hynan, L. S., Lucarelli, R. T., & King, K. S. (2015) · Radiology · doi:10.1148/radiol.2015142488 · Cited by 43 · see citing works

Increased transcription and activity of glutathione synthase in response to deficiencies in folate, vitamin E, and apolipoprotein E

Tchantchou, F., Graves, M. V., Ashline, D. J., Morin, A., Pimenta, A., Ortiz, D., Rogers, E. J., & Shea, T. B. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.10867 · Cited by 42 · see citing works

Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study

Loers, G., Aboul‐Enein, F., Bartsch, U., Lassmann, H., & Schachner, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.06.006 · Cited by 42 · see citing works

N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases

Martı́nez, M. (2022) · Antioxidants · doi:10.3390/antiox11020416 · Cited by 44 · see citing works

The Interaction of APOE Genotype by Age in Amnestic Mild Cognitive Impairment: A Voxel-Based Morphometric Study

Chen, J., Shu, H., Wang, Z., Liu, D., Shi, Y., Zhang, X., & Zhang, Z. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141677 · Cited by 41 · see citing works

A common variant located in the 3′UTR of theRET gene is associated with protection from Hirschsprung disease

Griseri, P., Lantieri, F., Puppo, F., Bachetti, T., Duca, M. D., Ravazzolo, R., & Ceccherini, I. (2006) · Human Mutation · doi:10.1002/humu.20397 · Cited by 35 · see citing works

Spatial memory deficits in a mouse model of late-onset Alzheimer’s disease are caused by zinc supplementation and correlate with amyloid-beta levels

Flinn, J. M., Bozzelli, P. L., Adlard, P. A., & Railey, A. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00174 · Cited by 35 · see citing works

Role of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease

Chen, X. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000236 · Cited by 30 · see citing works

Folate and Vitamin E Deficiency Impair Cognitive Performance in Mice Subjected to Oxidative Stress: Differential Impact on Normal Mice and Mice Lacking Apolipoprotein E

Mihalick, S. M., Ortiz, D., Kumar, R., Rogers, E. J., & Shea, T. B. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:3:197 · Cited by 30 · see citing works

Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology

Glass, D. J., & Arnold, S. E. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2408 · Cited by 29 · see citing works

Apo<scp>E</scp>: The role of conserved residues in defining function

Frieden, C. (2015) · Protein Science · doi:10.1002/pro.2597 · Cited by 29 · see citing works

Dietary Supplementation with Apple Juice Decreases Endogenous Amyloid-β Levels in Murine Brain

Chan, A., & Shea, T. B. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0959 · Cited by 29 · see citing works

Apolipoprotein E ɛ2 and Functional Decline in Amnestic Mild Cognitive Impairment and Alzheimer Disease

Bonner‐Jackson, A., Okonkwo, O. C., & Tremont, G. N. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182203c32 · Cited by 28 · see citing works

Cardiovascular Dementia - A Different Perspective

Kumari, U., & Heese, K. (2010) · The Open Biochemistry Journal · doi:10.2174/1874091x01004010029 · Cited by 27 · see citing works

The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals

Ingala, S., Mazzai, L., Sudre, C. H., Salvadó, G., Brugulat-Serrat, A., Wottschel, V., Falcon, C., Operto, G., Tijms, B., Gispert, J. D., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.015 · Cited by 25 · see citing works

Apolipoprotein E Polymorphism and Age at Onset of Alzheimer’s Disease in a Quadriethnic Sample

Kwon, O. D., Khaleeq, A., Chan, W., Pavlik, V., & Doody, R. S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000322368 · Cited by 24 · see citing works

Dietary Deficiency in Folate and Vitamin E Under Conditions of Oxidative Stress Increases Phospho-Tau Levels: Potentiation by ApoE4 and Alleviation by S-Adenosylmethionine

Chan, A., Rogers, E. J., & Shea, T. B. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1076 · Cited by 24 · see citing works

Positive association of a Sirt1 variant and parameters of oxidative stress on Alzheimer’s disease

Camporez, D., Belcavello, L., Almeida, J. F. F., Sena, G. G. S., Pimassoni, L. H. S., Morelato, R. L., Batitucci, M. D. C. P., & Paula, F. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04704-y · Cited by 19 · see citing works

Sex, but not Apolipoprotein E Polymorphism, Differences in Spatial Performance in Young Adults

Yasen, A. L., Raber, J., Miller, J. K., & Piper, B. J. (2015) · Archives of Sexual Behavior · doi:10.1007/s10508-015-0497-1 · Cited by 21 · see citing works

Predictors That a Diagnosis of Mild Cognitive Impairment Will Remain Stable 3 Years Later

Clem, M., Holliday, R., Pandya, S., Hynan, L., Lacritz, L., & Woon, F. (2017) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000119 · Cited by 23 · see citing works

Effects of Apolipoprotein E-ε4 and -ε2 in Amnestic Mild Cognitive Impairment and Dementia in Shanghai: SCOBHI-P

Borenstein, A. R., Mortimer, J. A., Ding, D., Schellenberg, G. D., DeCarli, C. S., Zhao, Q., Copenhaver, C. I., Guo, Q., Chu, S., Galasko, D. R., et al. (2010) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317509357736 · Cited by 20 · see citing works

Differential susceptibity of transgenic mice lacking one or both apolipoprotein alleles to folate and vitamin E deprivation

Shea, T. B., Ortiz, D., & Rogers, E. J. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6307 · Cited by 20 · see citing works

Basic research Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis

Al-Asmary, S. M., Kadasah, S., Arfin, M., Tariq, M., & Al-Asmari, A. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.53308 · Cited by 19 · see citing works

Haplotype architecture of the Alzheimer's risk in the APOE region via co‐skewness

Kulminski, A. M., Philipp, I., Loika, Y., He, L., & Culminskaya, I. V. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12129 · Cited by 18 · see citing works

Retinal microglia express more MHC class I and promote greater T-cell-driven inflammation than brain microglia

Bloomfield, C. L., Gong, J., Droho, S., Makinde, H. M., Gurra, M. G., Stumpf, C. H., Kharel, A., Gadhvi, G. T., Winter, D. R., Cui, W., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1399989 · Cited by 18 · see citing works

Apolipoprotein E and Measured Physical and Pulmonary Function in Older Taiwanese Adults

Vasunilashorn, S. M., Glei, D. A., Lin, Y., & Goldman, N. (2013) · Biodemography and Social Biology · doi:10.1080/19485565.2013.778703 · Cited by 17 · see citing works

Apolipoprotein E-Related Neurotoxicity as a Therapeutic Target for Alzheimer's Disease

Marques, M. A., & Crutcher, K. A. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:327 · Cited by 17 · see citing works

AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes

Rossello, X. S., Igbavboa, U., Weisman, G. A., Sun, G. Y., & Wood, W. G. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.017 · Cited by 16 · see citing works

Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation

Khan, N., Datta, G., Geiger, J. D., & Chen, X. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1129-1 · Cited by 16 · see citing works

Mediation of the APOE associations with Alzheimer’s and coronary heart diseases through body mass index and lipids

Loika, Y., Feng, F., Loiko, E., & Kulminski, A. M. (2021) · GeroScience · doi:10.1007/s11357-021-00458-3 · Cited by 14 · see citing works

Age at Onset: An Essential Variable for the Definition of Genetic Risk Factors for Sporadic Alzheimer's Disease

Beyer, K., Lao, J. I., Latorre, P., & Ariza, A. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb06138.x · Cited by 14 · see citing works

Genetic biomarkers of cognitive impairment and dementia of potential interest in CKD patients

Zoccali, C., & Capasso, G. (2024) · Journal of Nephrology · doi:10.1007/s40620-024-02006-6 · Cited by 9 · see citing works

Apolipoprotein E is associated with blood lipids and inflammation in Taiwanese older adults

Vasunilashorn, S. M., Glei, D. A., Lan, C.-Y., Brookmeyer, R., Weinstein, M., & Goldman, N. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.100 · Cited by 9 · see citing works

The S-Adenosyl Homocysteine Hydrolase Inhibitor 3-Deaza-Adenosine Prevents Oxidative Damage and Cognitive Impairment Following Folate and Vitamin E Deprivation in a Murine Model of Age-Related, Oxidative Stress-Induced Neurodegeneration

Shea, T. B., Ashline, D. J., Ortiz, D., Milhalik, S., & Rogers, E. J. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:171 · Cited by 8 · see citing works

Improved multimodal biomarkers for Alzheimer's disease and mild cognitive impairment diagnosis: data from ADNI

Martínez‐Torteya, A., Treviño, V., & Tamez‐Peña, J. G. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2008100 · Cited by 7 · see citing works

Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD

Chen, X., Liang, H., Soliman, M. L., & Geiger, J. D. (2014) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000002 · Cited by 7 · see citing works

Association of Alzheimer’s Disease with Genetic Variants of Apolipoprotein E, Clusterin, TNF-α, and IL-6 Among Elderly Saudis

Abdi, S., Alghamdi, A. A., AlGhunaim, N. N. A., Almutairi, R. M., Ataya, F. S., Ansari, M. G. A., Hussain, S. D., Masoud, M. S., Alamro, A. A., Almutairi, O. T., et al. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220208093919 · Cited by 7 · see citing works

Screening of Skin Lesion-Associated Genes in Patients with Psoriasis by Meta-Integration Analysis

Mei, R., & Mei, X. (2017) · Dermatology · doi:10.1159/000481619 · Cited by 5 · see citing works

Apolipoprotein E3 as a Risk Factor for Alzheimer's Disease Under Conditions of Nutritional Imbalance

Chan, A., & Shea, T. B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100060 · Cited by 4 · see citing works

A Missed Proteome in Living Organisms: A Hyppo System

Seong, S. (2006) · Current Proteomics · doi:10.2174/157016406778194644 · Cited by 5 · see citing works

Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer’s Dementia

Liampas, I., Demiri, S., Siokas, V., Tsika, A., Marogianni, C., Stamati, P., Nasios, G., Messinis, L., Lyketsos, C. G., & Dardiotis, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178562 · Cited by 3 · see citing works

Genomics

Winkelman, C. (2004) · Critical Care Nurse · doi:10.4037/ccn2004.24.3.34 · Cited by 3 · see citing works

Lipid Rafts and Neurological Diseases

Sonnino, S., Grassi, S., Prioni, S., Ciampa, M. G., Chiricozzi, E., & Prinetti, A. (2016) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0023405 · Cited by 3 · see citing works

Nutrigenetik: Genetische Varianz und Effekte der Ernährung

Daniel, H., & Klein, U. I. (2012) · Springer-Lehrbuch · doi:10.1007/978-3-642-29374-0_2 · Cited by 2 · see citing works

Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months

Regal, P. J., Nair, B., & Hetherington, E. J. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s47485 · Cited by 2 · see citing works

Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.

Chen, X., Liang, H., & Geiger, J. D. (2014) · PubMed · Cited by 2 · see citing works

Aortic Single-Cell Transcriptome Analysis Reveals ApoE-Isoform-Specific Influences on Vascular Disease

Hui, D. Y., Alagarsamy, J., Haller, A. M., Medvedovic, M., & Jaeschke, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125619 · Cited by 1 · see citing works

Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging

Kwon, O. D. (2016) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2016.15.3.61 · Cited by 1 · see citing works

IsoDA: Isoform–Disease Association Prediction by Multiomics Data Fusion

Huang, Q., Wang, J., Zhang, X., Guo, M., & Yu, G. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2020.0626 · Cited by 1 · see citing works

Neuroligins and Neurexins in Alzheimer’s disease

Sindi, I. A. (2014) · The University of Queensland · doi:10.14264/uql.2015.176

The Role of Lipoproteins/cholesterol in Genomic Instability and Chromosome Mis-segregation in Alzheimer's and Cardiovascular Disease

Granic, A. (2011) · Digital Commons - University of South Florida (University of South Florida)

Cognitive Impairment and the Dementias

Duara, R., Rodriguez, M. J., Loewenstein, D., Farlow, M. R., Ballard, C. G., Chui, H. C., Segal‐Gidan, F., Perry, D. C., Rosen, H. J., Henry, M. L., et al. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch9

The Effects That Dietary Manipulations of Zinc and Copper Have on Nest Building, Zinc Transporter and Glial Fibrillary Acidic Protein Expression in a Transgenic Mouse Model of Alzheimer’s Disease

Bozzelli, P. L. (2014) · doi:10.13021/mars/6103

Spine tingling polymorphisms—Is apolipoprotein E involved in dendritic shape and plasticity?

Spires‐Jones, T. L., & Hyman, B. T. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.038

Genetic Variation and Individualized Medicine

Mansell, J. L., Tierney, R., Driban, J. B., Clegg, S. M., Higgins, M. J., Mishra, A. K., & Krynetskiy, E. Y. (2010) · Journal of Sport Rehabilitation · doi:10.1123/jsr.19.4.389

HaploinsufficiencyofHumanAPOEReducesAmyloid DepositioninaMouseModelofAmyloid-Amyloidosis

Eltorai, M. (2011)

Clinical Validation of Neuronal Pentraxin Receptor as a Candidate Biomarker for Alzheimer’s Disease

Lim, B. (2020) · TSpace (University of Toronto)

Effects of aging and long-term dietary restrictions on cholesterol metabolism in the rat forebrain

Smiljanić, K. (2012) · doi:10.2298/bg20120709smiljanic

Age at natural menopause, reproductive lifespan and Alzheimer’s disease in females: is APOE ε4 the missing link?

Bruno, F., Spadafora, P., Abondio, P., Qualtieri, A., Paparazzo, E., Aceto, M. A., Veltri, I., Benedittis, S. D., Greco, B. M., Cerantonio, A., et al. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1733593

Connecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease

Foncea-Bitrán, A., Barros-Osorio, C., Arriaza, F., Ramírez-López, C., Ruíz, L. M., Barreto, M., Ortíz, F. C., Cornejo, F., & Gómez, G. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073225

Protective effect of apoE ∈2 in Alzheimer's disease

Benjamin, R., Leake, A., McArthur, F. K., Ince, P. G., Candy, J., Edwardson, J. A., Morris, C. M., & Bjertness, E. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91804-x · Cited by 67 · see citing works

Protection against Alzheimer's disease with apoE ∈2

Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J., & Goate, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92557-7 · Cited by 225 · see citing works

???Protective??? apoE isoforms provide new lead in Alzheimer??s therapy

Szeto, T. (1994) · Inpharma Weekly · doi:10.2165/00128413-199409410-00014

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease

Li, Z., Shue, F., Zhao, N., Shinohara, M., & Bu, G. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00413-4 · Cited by 306 · see citing works

The Apolipoprotein E €2 Allele Is Associated with an Increased Rsk of Early-Onset Alzheimer's Disease and a Reduced Survival

van Duijn, C. M., Jhijff, P. D., Wehnert, S. A., Voecht, J. D., Bronzova, J. B., Havekes, L. M., Hofman, T. A., & Broeckhoven, C. V. (2016)